Cargando…

Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity

Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinothkumar, Kutti R., Pierrat, Olivier A., Large, Jonathan M., Freeman, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690538/
https://www.ncbi.nlm.nih.gov/pubmed/23665170
http://dx.doi.org/10.1016/j.str.2013.03.013
_version_ 1782274385224138752
author Vinothkumar, Kutti R.
Pierrat, Olivier A.
Large, Jonathan M.
Freeman, Matthew
author_facet Vinothkumar, Kutti R.
Pierrat, Olivier A.
Large, Jonathan M.
Freeman, Matthew
author_sort Vinothkumar, Kutti R.
collection PubMed
description Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in complex with β-lactam inhibitors. The inhibitors form a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of β-lactam inhibitors points into a cavity within the enzyme, providing a structural explanation for the specificity of β-lactams on rhomboid proteases. This same cavity probably represents the S2′ substrate binding site of GlpG. We suggest that the structural changes in β-lactam inhibitor binding reflect the state of the enzyme at an initial stage of substrate binding to the active site. The structural insights from these enzyme-inhibitor complexes provide a starting point for structure-based design for rhomboid inhibitors.
format Online
Article
Text
id pubmed-3690538
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-36905382013-06-24 Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity Vinothkumar, Kutti R. Pierrat, Olivier A. Large, Jonathan M. Freeman, Matthew Structure Short Article Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in complex with β-lactam inhibitors. The inhibitors form a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of β-lactam inhibitors points into a cavity within the enzyme, providing a structural explanation for the specificity of β-lactams on rhomboid proteases. This same cavity probably represents the S2′ substrate binding site of GlpG. We suggest that the structural changes in β-lactam inhibitor binding reflect the state of the enzyme at an initial stage of substrate binding to the active site. The structural insights from these enzyme-inhibitor complexes provide a starting point for structure-based design for rhomboid inhibitors. Cell Press 2013-06-04 /pmc/articles/PMC3690538/ /pubmed/23665170 http://dx.doi.org/10.1016/j.str.2013.03.013 Text en © 2013 ELL & Excerpta Medica. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Short Article
Vinothkumar, Kutti R.
Pierrat, Olivier A.
Large, Jonathan M.
Freeman, Matthew
Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
title Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
title_full Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
title_fullStr Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
title_full_unstemmed Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
title_short Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ Cavity
title_sort structure of rhomboid protease in complex with β-lactam inhibitors defines the s2′ cavity
topic Short Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690538/
https://www.ncbi.nlm.nih.gov/pubmed/23665170
http://dx.doi.org/10.1016/j.str.2013.03.013
work_keys_str_mv AT vinothkumarkuttir structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity
AT pierratoliviera structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity
AT largejonathanm structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity
AT freemanmatthew structureofrhomboidproteaseincomplexwithblactaminhibitorsdefinesthes2cavity